Bausch Health’s DUOBRII lotion now available in U.S.; shares up 4% premarket

Bausch Health Companies (NYSE:BHC) has launched DUOBRII (halobetasol propionate and tazarotene) Lotion, 0.01%/0.045% in U.S. for patients with plaque psoriasis.

The FDA approved DUOBRII is the first and only topical lotion that contains a unique combination of halobetasol propionate and tazarotene in one formulation.

DUOBRII Lotion is priced at $825 for a a 100-gram tube.

Shares are up 4% premarket

https://seekingalpha.com/news/3473506-bausch-healths-duobrii-lotion-now-available-u-s-shares-4-percent-premarket